Noninterventional Study Assessing Cognitive Function and Physical Activity in People With Multiple Sclerosis

• Status: Completed
• Trial end date: 2017-04-05

Summary

Study assessing cognitive function and physical activity in people with relapsing remitting multiple sclerosis.

Details

• Lead Sponsor: Bayer
• Treatments: Interferon beta-1b; Interferon-beta; Interferons